A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD

NCT06205095 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Von Willebrand Diseases

Interventions

DRUG: Lyophilized concentrate of human coagulation von Willebrand Factor and factor VIII
OTHER: Placebo

Sponsor

Unity Health Toronto